PGY2 ID Pharmacy Resident - Pediatrics for 2025 - 2026

St. Jude Children’s Research Hospital (St. Jude) in collaboration with Le Bonheur Children’s Hospital (LBCH) offers a 12-month (minimum of 52 week) ASHP accredited PGY2 Infectious Diseases Pharmacy Residency with a focus on pediatrics. The St. Jude / LBCH partnership provides the resident advanced training with experienced preceptors in ID pharmacotherapy for a diverse range of pediatric patient populations including those with immunocompromise. The resident will gain clinical experience at both sites with general ID consult services and transplant ID consult services for bone marrow and solid organ transplant. St. Jude offers special ID experiences in oncology and non-malignant hematology (primarily sickle cell disease). LBCH offers ID experiences in general pediatrics and critical care. LBCH (with UTHSC) offers extensive academic opportunities including didactic lectures and precepting students on clinical rotation. The resident will be expected to complete a major project relevant to infectious diseases. Experiences during the residency will enable the resident to pursue a career in infectious diseases serving a wide range of pediatric populations.